Healthcare Realty Trust Incorporated – Consensus ‘buy’ rating and 2.3% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Healthcare Realty Trust Incorporated with ticker code (HR) have now 7 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $19.00 and $15.00 calculating the average target price we see $17.71. Given that the stocks previous close was at $17.31 this now indicates there is a potential upside of 2.3%. Also worth taking note is the 50 day moving average now sits at $15.64 and the 200 day moving average is $17.47. The company has a market cap of 6.57B. The current share price for the company is: $17.25 USD

The potential market cap would be $6,721,897,677 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $3.56 and a 0.27% return on assets.

Healthcare Realty Trust Inc is a self-managed and self-administered real estate investment trust (REIT). The Company owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. It acquires properties from health systems, developers, physician groups, and other private investors. Its portfolio includes Pomerado Outpatient Pavilion, Porter Adventist Mob Portfolio, Taj Mahal Medical Center, Penrose Pavilion, Church Street Mobs, Parkway Professional Mob I And II, Clearview Mob I And Mob II, Highmark Medical Center, Valley Medical Center, 2100 Exeter Road, Mid-State Medical Center, Pima Medical Pavilion I & II, and others. It has invested in approximately 721 real estate properties in 35 states totaling approximately 42 million square feet. It provides leasing and property management services to more than 39 million square feet nationwide.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search